Immunic

+$0.68 (+5.44%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Immunic and other stocks, options, and ETFs commission-free!

About IMUX

Immunic, Inc. Common Stock, also called Immunic, is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases.

CEO
Daniel Vitt
Employees
28
Headquarters
New York, New York
Founded
2003

IMUX Key Statistics

Market Cap
284.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
173.79K
High Today
$13.50
Low Today
$12.30
Open Price
$12.45
Volume
146.20K
52 Week High
$28.21
52 Week Low
$9.00

IMUX Earnings

-$1.63
-$1.09
-$0.54
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.71 per share
Actual
-$1.63 per share

You May Also Like

PALI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure